Page last updated: 2024-08-24

lamivudine and Blood Poisoning

lamivudine has been researched along with Blood Poisoning in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Battegay, M; Cueni, N; Dickenmann, M; Hollinger, A; Landmann, E; Leuppi-Taegtmeyer, A; Martinez, AE; Marzolini, C; Siegemund, M1
Boninsegna, S; Caroli, D; Fagiuoli, S; Floreani, A; Lobello, S1
Devecioglu, C; Dikici, B; Ece, A; Haspolat, K; Söker, M1

Reviews

2 review(s) available for lamivudine and Blood Poisoning

ArticleYear
Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.
    AIDS research and therapy, 2021, 09-04, Volume: 18, Issue:1

    Topics: Acidosis, Lactic; Aged; Anti-HIV Agents; HIV Infections; Humans; Hyperlactatemia; Kidney Transplantation; Lamivudine; Male; Sepsis

2021
Interferon-alpha treatment as a possible cause of relapse in a child with precursor B acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Fatal Outcome; Hepatitis B, Chronic; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Sepsis

2001

Other Studies

1 other study(ies) available for lamivudine and Blood Poisoning

ArticleYear
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal.
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2

    Topics: Bone Marrow Transplantation; Fatal Outcome; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency; Reverse Transcriptase Inhibitors; Sepsis; Virus Activation

2006